Zobrazeno 1 - 10
of 81
pro vyhledávání: '"G, Poggiopollini"'
Autor:
Donatella Magalotti, Serafina Antonelli, Giampaolo Bianchi, Susanna Dapporto, Marco Zoli, Antonio Muscari, Giulia Cavrini, Amedeo Ligabue, G. Poggiopollini, Cosimo Ludovico
Publikováno v:
Diabetes Care. 30:2362-2368
OBJECTIVE—This study was performed to ascertain the relative relevance of some inflammatory markers in insulin resistance. RESEARCH DESIGN AND METHODS—Four inflammatory markers (leukocyte count, erythrocyte sedimentation rate [ESR], high-sensitiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4487e2e7dafe20c578369ac07b72dd1a
https://doi.org/10.2337/dc07-0637
https://doi.org/10.2337/dc07-0637
Autor:
O. Cappelletti, Cristian Martignani, Giovanni Ravaglia, V. Tomassetti, L. Baldini, Paolo Emilio Puddu, G. Poggiopollini, P. Boni, Luciana Bastagli, Antonio Muscari
Publikováno v:
European Journal of Vascular and Endovascular Surgery. 26(1):81-87
Objectives: to test the hypothesis that some acute phase proteins may be better independent predictors of objective measures of arterial wall impairment than traditional risk factors. Design: cross-sectional study. Materials and Methods: C-reactive p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca0e65e2dc3697c493bb6f2aa8d6da56
Autor:
V. Tomassetti, Luciana Bastagli, L. Platè, G. Poggiopollini, P. Boni, Antonio Muscari, Paolo Emilio Puddu, O. Cappelletti, Massarelli G
Publikováno v:
International Journal of Cardiology. 83:63-71
Background: Some acute phase proteins are associated with both ischemic events and traditional risk factors. Since they are strongly interrelated, each of them partly reflects the characteristics of other proteins. This study was carried out to ascer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b6b936d65d7e9d3683b7a5e49d11866
https://doi.org/10.1016/s0167-5273(02)00017-7
https://doi.org/10.1016/s0167-5273(02)00017-7
Autor:
Cristina Legnani, P. Boni, Antonio Muscari, G. Drago, Angela Barini, Paolo Emilio Puddu, Luciana Bastagli, Tomassetti, O. Cappelletti, Maria Cristina Mele, G. Poggiopollini
Publikováno v:
Acta Cardiologica. 56:303-311
Objective -To establish which traditional and conditional risk factors were effectively treated, and which remained active, in patients with previous myocardial infarction (PMI). Methods and results - In 47 PMI patients recently submitted to cardiolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c54606c14b277f4958e264a9debdc47
https://doi.org/10.2143/ac.56.5.2005691
https://doi.org/10.2143/ac.56.5.2005691
Autor:
Massarelli G, Antonio Muscari, P. Boni, Luciana Bastagli, V. Tomassetti, G. Poggiopollini, Paolo Emilio Puddu
Publikováno v:
Cardiovascular Drugs and Therapy. 15:453-458
C3 complement is produced in response to macrophage activation and is a reliable marker of the risk of myocardial infarction in men. This study was designed to ascertain whether the treatment with atorvastatin, a powerful cholesterol lowering drug, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b810c281594d19c1120988041cbb3e1
https://doi.org/10.1023/a:1013314227857
https://doi.org/10.1023/a:1013314227857
Autor:
G. Poggiopollini, Antonio Muscari, P. Pacilli, G. Drago, Paolo Emilio Puddu, Cristian Martignani, P Boni, Luciana Bastagli, V. Tomassetti, Massarelli G
Publikováno v:
European Heart Journal. 21:1081-1090
Aims Serum C3 is a powerful indicator of the risk of myocardial infarction, which correlates with body mass index, serum lipids and blood pressure. This study was performed to ascertain whether such correlations may be explained by an association of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b8649cf8d4a61e2c4c2bdd249c6a69d
https://doi.org/10.1053/euhj.1999.2013
https://doi.org/10.1053/euhj.1999.2013
Autor:
MUSCARI, ANTONIO, BIANCHI, GIAMPAOLO, DAPPORTO, SUSANNA, MAGALOTTI, DONATELLA, ZOLI, MARCO, S. Antonelli, G. Cavrini, A. Ligabue, C. Ludovico, G. Poggiopollini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4094::df5a21ee28964c1ee0e807c50afcf532
http://hdl.handle.net/11585/48444
http://hdl.handle.net/11585/48444
Autor:
Claudio Tentoni, Elia Foschi, Claudia Giannoni, Lucia Pierpaoli, Giampaolo Bianchi, Donatella Magalotti, Antonio Muscari, Annalisa Berzigotti, G. Poggiopollini, Marco Zoli, Pasqualino Maietta, Carlo Ravaioli
Publikováno v:
International journal of geriatric psychiatry. 25(10)
Objective To evaluate the effects of endurance exercise training (EET) on the cognitive status of healthy community-dwelling older adults. Methods A randomized controlled trial was conducted involving community-dwelling older adults from the town of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd170b45ac9abe6cd8c4939654afccf6
https://pubmed.ncbi.nlm.nih.gov/20033904
https://pubmed.ncbi.nlm.nih.gov/20033904
Autor:
Paola Forti, Dario Sbano, Antonio Muscari, G. Poggiopollini, Luciana Bastagli, Marco Zoli, Paolo Emilio Puddu, V. Tomassetti, Giovanni Ravaglia, P. Boni
Background Serum C3 is an inflammatory predictor of myocardial infarction and a covariate of fasting insulin and several endogenous risk factors. This study was performed to ascertain whether risk factor control may reduce elevated C3 concentrations.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d57729c13be220847809b19f667ed5b1
http://hdl.handle.net/11585/5306
http://hdl.handle.net/11585/5306
Publikováno v:
Cardiovascular drugs and therapy. 15(5)
C3 complement is produced in response to macrophage activation and is a reliable marker of the risk of myocardial infarction in men. This study was designed to ascertain whether the treatment with atorvastatin, a powerful cholesterol lowering drug, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::51cebafdf1057ec25250254467bef316
https://pubmed.ncbi.nlm.nih.gov/11855664
https://pubmed.ncbi.nlm.nih.gov/11855664